FIELD: medicine.
SUBSTANCE: immunomodulatory drug Panavir is used intravenously 200 mkg in complex of erythroderma psoriaticum treatment. The first three injections are given every second day, the following two injections are given every 48 hours. The course of treatment lasts for 1.5-2 weeks up to average values of index PASI 6.4-7.5.
EFFECT: high cure rate, recrudescence duration decrease, eliminated side effects, extended remission period.
2 ex, 1 tbl
| Title | Year | Author | Number |
|---|---|---|---|
| METHOD OF TREATING PSORIATIC ERYTHRODERMA | 2011 |
|
RU2496498C2 |
| METHOD OF PSORIASIS TREATMENT | 2007 |
|
RU2361605C2 |
| METHOD OF EXTERNAL TREATMENT OF PSORIATIC ONYCHODYSTROPHY | 2011 |
|
RU2462232C1 |
| METHOD OF TREATING PSORIASIS | 2009 |
|
RU2394575C1 |
| METHOD OF TREATING PSORIASIS VULGARIS | 2011 |
|
RU2472541C1 |
| METHOD FOR TREATING PSORIASIS | 2006 |
|
RU2322255C1 |
| METHOD OF TREATING LICHEN RUBER PLANUS | 2008 |
|
RU2367445C1 |
| METHOD OF TREATING PATIENTS WITH PSORIASIS IN PROGRESSING STAGE | 2019 |
|
RU2716617C1 |
| METHOD OF TREATING GUTTATE PSORIASIS | 2011 |
|
RU2483762C2 |
| METHOD FOR EXTERNAL TREATMENT OF PSORIATIC ONYCHODYSTROPHY | 2021 |
|
RU2773804C1 |
